Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,121,941 | -22.4% | 389,347 | -3.3% | 0.00% | -100.0% |
Q2 2023 | $2,734,000 | +186.0% | 402,651 | +111.0% | 0.00% | – |
Q1 2023 | $955,863 | -38.2% | 190,791 | -39.8% | 0.00% | – |
Q4 2022 | $1,546,237 | -41.4% | 316,852 | +73.1% | 0.00% | -100.0% |
Q3 2022 | $2,640,000 | +15.0% | 183,077 | +20.7% | 0.00% | 0.0% |
Q2 2022 | $2,296,000 | +53.3% | 151,726 | +20.3% | 0.00% | – |
Q1 2022 | $1,498,000 | -57.5% | 126,111 | -42.0% | 0.00% | -100.0% |
Q4 2021 | $3,523,000 | -84.8% | 217,361 | -73.3% | 0.00% | -80.0% |
Q3 2021 | $23,213,000 | -16.3% | 813,355 | -0.9% | 0.01% | -16.7% |
Q2 2021 | $27,733,000 | +12.1% | 820,482 | +0.3% | 0.01% | 0.0% |
Q1 2021 | $24,732,000 | -42.0% | 817,849 | -5.1% | 0.01% | -45.5% |
Q4 2020 | $42,650,000 | +53.0% | 861,438 | +18.6% | 0.01% | +37.5% |
Q3 2020 | $27,876,000 | +11.3% | 726,117 | +25.2% | 0.01% | 0.0% |
Q2 2020 | $25,050,000 | +94.0% | 579,878 | +17.2% | 0.01% | +60.0% |
Q1 2020 | $12,910,000 | -28.4% | 494,641 | -14.3% | 0.01% | 0.0% |
Q4 2019 | $18,026,000 | +163.5% | 576,846 | +119.8% | 0.01% | +150.0% |
Q3 2019 | $6,840,000 | +32.4% | 262,456 | +16.2% | 0.00% | +100.0% |
Q2 2019 | $5,166,000 | -12.3% | 225,867 | +0.5% | 0.00% | -50.0% |
Q1 2019 | $5,891,000 | +21.8% | 224,765 | -5.5% | 0.00% | 0.0% |
Q4 2018 | $4,836,000 | -41.5% | 237,778 | -23.6% | 0.00% | 0.0% |
Q3 2018 | $8,266,000 | – | 311,210 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 2,104,278 | $55,890,000 | 4.98% |
SCOPIA CAPITAL MANAGEMENT LP | 1,587,566 | $42,166,000 | 0.81% |
DC Investments Management, LLC | 25,000 | $664,000 | 0.45% |
Monashee Investment Management LLC | 67,800 | $1,801,000 | 0.38% |
Avoro Capital Advisors LLC | 310,000 | $8,234,000 | 0.38% |
Cormorant Asset Management, LP | 200,000 | $5,312,000 | 0.34% |
PURA VIDA INVESTMENTS, LLC | 22,350 | $594,000 | 0.12% |
Artal Group S.A. | 150,000 | $3,984,000 | 0.10% |
OXFORD ASSET MANAGEMENT LLP | 59,122 | $1,556,000 | 0.03% |
Point72 Hong Kong Ltd | 3,252 | $86,000 | 0.03% |